Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zoledronic Acid and Simvastatin in Breast Cancer With Bone Metastasis
NCT07823751Completed
- Sponsor
- Universitas Indonesia
- Start
- Apr 2021
- Primary completion
- Apr 2023
- Countries
- 1
01
Overview
Randomised, double-blind trial in breast cancer comparing ZA + Simvastatin with ZA + Placebo (2 arms). Primary endpoint: Change in Serum DKK-1 Level at 18 weeks. Started Apr 2021; status: completed.
02
Drugs
simvastatin
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT07823751.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07823751.